Stock Events

Stock Events

Search...

MoonLake Immunotherapeutics (MLTX) Q3 2025 Earnings

5AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.87

-0.73

-0.58

-0.44

Details

Expected EPS

-0.74038

Actual EPS

-0.87

Surprise EPS

-0.13

Surprise Percent

+17.51%

Description

MoonLake Immunotherapeutics (MLTX) has reported earnings of -0.87 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.